Pharmaceutical Contract Manufacturing And Research Services Market In-Depth Research On Basis Of Service, Region And Forecast To 2028
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjkyF4Sovys45-kv0PAMKZF_QhdAmgodz86G1zgkwVOIy_Yv7h-tiQWK9oDM4qaCfXq365nukVmgym8C42IUDGDuEfFxuzmEoO-a46SL6jQz4TFMnsDrZs6ULfcpi6omcSv3imBXZEOvfaR/s320/Pharmaceutical+Contract+Manufacturing+And+Research+Services+Market.png)
San Francisco, 24 Aug 2021: The Report Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report By Service (Manufacturing, Research), By Region, And Segment Forecasts, 2021 - 2028 The global pharmaceutical contract manufacturing and research services market size is expected to reach USD 276.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.75% from 2021 to 2028. The rising investments in R&D, increasing demand for generics, and the growing aging population with various chronic diseases are responsible for market growth. The focus of large pharmaceutical companies to strategically engage with a small number of preferred providers is a meaningful solution from procurement-based outsourcing. This was one of the many business traits that this service industry has become accustomed to. Service providers that hold the potential of providing cost and quality advantages